📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Avantec Vascular

1.1 - Company Overview

Avantec Vascular Logo

Avantec Vascular

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of coronary and peripheral vascular medical devices, including the Duraflex Coronary Stent System for vascular disease treatment, Apollo Coronary Dilatation Catheter, Captus Vascular Retrieval System for retrieving foreign objects (guide wires, coils, balloons, catheters, filters), neurovascular and peripheral coils, peripheral atherectomy, and specialty coronary/peripheral drug-eluting stents.

Products and services

  • Duraflex™ Coronary Stent System: Interventional-grade coronary stent system designed for the treatment of vascular disease in coronary arteries by Avantec Vascular Corporation
  • Specialty Coronary / Peripheral DES: Custom-engineered drug-eluting stents designed for coronary and peripheral vascular applications from Avantec Vascular Corporation, built to address diverse vascular treatment needs
  • Captus Vascular Retrieval System: Interventional-grade device intended for use in the cardiovascular system to retrieve foreign objects such as guide wires, coils, balloons, catheters, and filters

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Avantec Vascular

VasoNova Logo

VasoNova

HQ: United States Website
  • Description: Provider of medical devices, including a self-guided PICC catheter; develops, manufactures, and markets these products. Based in Sunnyvale, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VasoNova company profile →
Okami Medical Logo

Okami Medical

HQ: United States Website
  • Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okami Medical company profile →
Ablacon Logo

Ablacon

HQ: United States Website
  • Description: Provider of AI-guided atrial fibrillation therapies, including the Ablamap System to localize and characterize functional mechanisms of AF for customized ablation; the Ablacath Mapping Catheter, used with Ablamap to identify and ablate sources outside the pulmonary veins; and the EGF Mapping System using electrographic flow mapping to detect and quantify patterns of electrical wavefront propagation in the atria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ablacon company profile →
Renovacor Logo

Renovacor

HQ: United States Website
  • Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renovacor company profile →
Infraredx Logo

Infraredx

HQ: United States Website
  • Description: Provider of catheter-based coronary imaging devices utilizing near-infrared spectroscopy (NIRS) to identify and characterize vulnerable plaque, alongside CME-accredited webinar and educational sessions on polyvascular disease management, intravascular coronary imaging, coronary physiology, patient risk assessment, and imaging-guided interventions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Infraredx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Avantec Vascular

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Avantec Vascular

2.2 - Growth funds investing in similar companies to Avantec Vascular

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Avantec Vascular

4.2 - Public trading comparable groups for Avantec Vascular

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Avantec Vascular

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Avantec Vascular

What does Avantec Vascular do?

Avantec Vascular is a provider of coronary and peripheral vascular medical devices, including the Duraflex Coronary Stent System for vascular disease treatment, Apollo Coronary Dilatation Catheter, Captus Vascular Retrieval System for retrieving foreign objects (guide wires, coils, balloons, catheters, filters), neurovascular and peripheral coils, peripheral atherectomy, and specialty coronary/peripheral drug-eluting stents.

Who are Avantec Vascular's competitors?

Avantec Vascular's competitors and similar companies include VasoNova, Okami Medical, Ablacon, Renovacor, and Infraredx.

Where is Avantec Vascular headquartered?

Avantec Vascular is headquartered in United States.

How many employees does Avantec Vascular have?

Avantec Vascular has 1,000 employees 🔒.

When was Avantec Vascular founded?

Avantec Vascular was founded in 2010 🔒.

What sector and industry vertical is Avantec Vascular in?

Avantec Vascular is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Avantec Vascular

Who are the top strategic acquirers in Avantec Vascular's sector and industry

Top strategic M&A buyers and acquirers in Avantec Vascular's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Avantec Vascular?

Top strategic M&A buyers groups and sectors for Avantec Vascular include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Avantec Vascular's sector and industry vertical

Which are the top PE firms investing in Avantec Vascular's sector and industry vertical?

Top PE firms investing in Avantec Vascular's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Avantec Vascular's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Avantec Vascular's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Avantec Vascular's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Avantec Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Avantec Vascular's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Avantec Vascular?

The key public trading comparables and valuation benchmarks for Avantec Vascular include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Avantec Vascular for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Avantec Vascular with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Avantec Vascular's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Avantec Vascular with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Avantec Vascular's' sector and industry vertical?

Access recent funding rounds and capital raises in Avantec Vascular's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Avantec Vascular

Launch login modal Launch register modal